Cited 0 time in
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 EQUIVALENCE TRIAL COMPARING THE ETANERCEPT BIOSIMILAR, HD203,WITH ENBREL, IN COMBINATION WITH METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA).
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 배상철 | - |
| dc.date.accessioned | 2021-08-03T09:50:47Z | - |
| dc.date.available | 2021-08-03T09:50:47Z | - |
| dc.date.issued | 2014-06-11 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/44006 | - |
| dc.title | A RANDOMIZED, DOUBLE-BLIND, PHASE 3 EQUIVALENCE TRIAL COMPARING THE ETANERCEPT BIOSIMILAR, HD203,WITH ENBREL, IN COMBINATION WITH METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA). | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | Annual European Congress of Rheumatology | - |
| dc.citation.conferencePlace | Paris, France | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
